Description
What is the Cutting Stack?
Cutting Stack is a scientifically formulated subcutaneous pen designed for research protocols related to fat reduction, muscle preservation, and improved metabolic efficiency. It consists of three active compounds—Ostarine (MK2866), GW501516 (Cardarine), and SLU-PP-332—each with a specific mechanism of action targeting different aspects of body composition.
The total of 160.8mg in 3ml is precisely stabilized and pre-mixed for subcutaneous use, ensuring high bioavailability, accurate dosing, and minimal risk of error during research applications.
Key Components and Mechanism of Action:
Ostarine (MK2866) is one of the most well-studied selective androgen receptor modulators (SARMs), used for preserving muscle tissue during caloric restriction or catabolic states. It works by selectively binding to androgen receptors in muscle tissue, stimulating protein synthesis and enhancing nitrogen retention—without significantly affecting the hormonal axis. MK2866 is widely used in research protocols targeting smooth and controlled body recomposition.
GW501516 (Cardarine) is a PPAR-δ agonist that influences fatty acid and glucose metabolism, enhances mitochondrial activity, and increases endurance. Due to these properties, GW501516 is frequently used in protocols aimed at improving aerobic performance, metabolic adaptation, and lipid regulation.
SLU-PP-332 is an experimental PGC-1α modulator that supports mitochondrial biogenesis and cellular energy regulation. In research settings, it is studied for its ability to improve the oxidative capacity of muscle tissue, enhancing fat utilization for energy without directly affecting the androgenic or endocrine systems.
Synergistic Effect of the Cutting Stack:
The combined effect of MK2866, GW501516, and SLU-PP-332 forms a multi-component system aimed at preserving lean muscle during caloric deficit, mobilizing fat stores, and enhancing mitochondrial efficiency. Ostarine stabilizes muscle structure, while Cardarine and SLU-PP-332 activate distinct metabolic pathways for adaptation and energy expenditure.
This stack is highly suitable for protocols focused on optimizing body composition without hormonal suppression, with emphasis on metabolic balance, endurance, and recovery.
Scientifically Supported Potential Benefits:
Cutting Stack is designed to support the body during caloric deficits and high metabolic demand without compromising muscle integrity.
- Helps preserve lean muscle mass during caloric restriction
- Stimulates fat oxidation and improves mitochondrial efficiency
- Enhances physical endurance and workload adaptation
- Improves glucose and lipid metabolism without androgenic activity
- Suitable for research protocols focused on body recomposition and cutting phases
- Can be used in protocols aiming for targeted metabolic adaptation without systemic hormonal disruption
Dosage and Use in Research Protocols:
Recommended research protocol: 10 units once daily, for a duration of 4–8 weeks, followed by a rest period of 3–5 weeks.
Total pen content: 300 units
Maintaining optimal dosage and monitoring application duration play a crucial role in limiting the manifestation of side effects.
Possible Side Effects:
Currently, there is insufficient published clinical data regarding long-term usage profiles. In laboratory settings, tolerability is generally good, but as with any compound administered subcutaneously, individual reactions cannot be excluded.
Potential local effects related to the application method may include redness, sensitivity, discomfort, or mild swelling at the injection site. In longer cycles and higher doses, some models have explored possible effects on endogenous hormonal regulation, which may vary depending on dosage, duration, and individual sensitivity.
Strict monitoring of both dosage and duration is recommended for all research protocols.
For laboratory purposes and personal observation only.
